Skip to main content

Peer Review reports

From: A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)

Original Submission
12 Oct 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
13 Nov 2023 Reviewed Reviewer Report
24 Nov 2023 Reviewed Reviewer Report
1 Dec 2023 Reviewed Reviewer Report
4 Dec 2023 Reviewed Reviewer Report - Santhosh Shanthi Bhupathi
25 Dec 2023 Author responded Author comments - Mehmet Emin Buyukbayram
Resubmission - Version 3
25 Dec 2023 Submitted Manuscript version 3
28 Dec 2023 Author responded Author comments - Mehmet Emin Buyukbayram
Resubmission - Version 4
28 Dec 2023 Submitted Manuscript version 4
28 Dec 2023 Author responded Author comments - Mehmet Emin Buyukbayram
Resubmission - Version 5
28 Dec 2023 Submitted Manuscript version 5
5 Jan 2024 Reviewed Reviewer Report - Santhosh Shanthi Bhupathi
9 Jan 2024 Reviewed Reviewer Report
14 Jan 2024 Reviewed Reviewer Report
16 Jan 2024 Reviewed Reviewer Report
3 Apr 2024 Author responded Author comments - Mehmet Emin Buyukbayram
Resubmission - Version 6
3 Apr 2024 Submitted Manuscript version 6
17 Apr 2024 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
6 May 2024 Editorially accepted
23 May 2024 Article published 10.1186/s12885-024-12347-x

You can find further information about peer review here.

Back to article page